Junk Fine But Bewar...
Health Care: Drugs
pSivida Ltd. (PSDV: NASDAQ)
$3.94 0.10 | 2.60%
06/19/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.94 |
| 52 Week High | 4.03 |
| 52 Week Low | 1.17 |
| Avg. Daily Vol. (Mil) | 0.14 |
| Beta (3 year) | 1.70 |
| Share Related Items | |
| Mkt Cap (Mil) | 91.79 |
| Shares Out (Mil) | 23.30 |
| Float (Mil) | 20.53 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.50 |
| Current Ratio | 5.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 39.06 |
| Price/Book | 8.17 |
| Price/Cash Flow | -3.80 |
| Per Share Data | |
| Earnings | -0.44 |
| Sales | 0.10 |
| Book Value | 0.48 |
| Cash Flow | -1.02 |
| Business Summary | |
|---|---|
| PSivida Ltd. develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. | |
| General Information | |
| 400 Pleasant Street
Watertown, MA 02472 |
|
| www.psivida.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 29 | |
| CEO: Dr. Paul Ashton | |
| Short Interest | |
| Current Month (Mil) | 0.44 |
| Previous Month (Mil) | 0.33 |
| Short Interest Ratio (Days) | 2.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -53.40 |
| Return on Investments | -90.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with PSDV
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
Latest PSDV Headlines from TheStreet
- 4 Stocks Under $10 Making Big Moves 05.29.13 | 02:05 pm
- 5 Stocks Under $10 Set to Surge 05.02.13 | 02:05 pm
- 4 Stocks Under $10 Making Big Moves 07.24.12 | 02:07 pm
- 5 Stocks Poised for Breakouts 06.29.12 | 12:06 pm
- 5 Stocks Setting Up to Break Out 04.25.12 | 11:04 am
- 8 Stocks Under $10 Moving Higher 03.27.12 | 02:03 pm
- 5 Stocks Under $5 Making Big Moves 02.24.12 | 02:02 pm
- Biotech Calendar: Key Dates for November 11.01.11 | 10:11 am
- pSivida - Upgrades & Downgrades 09.24.10 | 01:09 pm
- Biotech Stocks Under $5
12.23.09 | 05:12 pm
Press Releases for PSDV
- PSivida Corp. Announces UK’s NICE Says Yes To ILUVIEN® In Some Patients With Diabetic Macular Edema In New Draft Guidance - Business Wire 06.14.13 | 08:06 am
- PSivida Reports Updates On ILUVIEN® For Planned Resubmission To FDA And European Launch - Business Wire 03.22.13 | 08:03 am
- PSivida VP Of Research To Discuss Company’s Protein And Antibody Sustained Delivery System At 5th Ocular Diseases And Drug Development Conference - Business Wire 03.20.13 | 01:03 pm
- PSivida Corp. Reports Second Quarter Fiscal Year 2013 Results - Business Wire 02.06.13 | 04:02 pm
- PSivida CEO To Present At 15th Annual BioCEO & Investor Conference February 12 - Business Wire 02.04.13 | 11:02 am
- PSivida Corp. Announces Second Quarter 2013 Financial Results Release Date And Conference Call Information - Business Wire 01.30.13 | 04:01 pm
- Psivida Corp. Announces Final Published Guidance From U.K.’s Nice And Pursuit Of Patient Access Scheme For Iluvien® For DME - Business Wire 01.23.13 | 07:01 am
- PSivida Corp. Announces Spain Grants ILUVIEN® Marketing Approval For Chronic Diabetic Macular Edema - Business Wire 01.17.13 | 07:01 am
- PSivida Corp. Reports Patient Access Scheme Being Developed By Alimera To Address Cost Concerns Following Negative Final Draft Guidance By U.K.’s NICE For ILUVIEN® For DME - Business Wire 11.29.12 | 07:11 pm
- PSivida Corp. Reports First Quarter Fiscal Year 2013 Results - Business Wire 11.08.12 | 04:11 pm
Partner Headlines for PSDV
- pSivida Drug Technology And Pipeline Make It One Of The Most Undervalued Biotechs For 2013 - Seeking Alpha 06.05.13 | 09:06 am
- Benzinga's Microcap Movers for Friday July 27, 2012 - Benzinga 07.29.12 | 09:07 am
- Healthcare Business Review: pSivida's CURES Blindness, Baxter's DUTCH Deal - Wall St. Cheat Sheet 07.20.12 | 09:07 am
- Psivida Licensee Set For European Launch By Year's End - Seeking Alpha 04.11.12 | 09:04 am
- Benzinga's Microcap Movers for Friday February 24, 2012 - Benzinga 02.26.12 | 04:02 pm
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 19 High Growth Micro Cap Stocks Under $10 - Seeking Alpha 01.23.11 | 07:01 am
- Alimera Gets Unwelcome Christmas Message From FDA - Seeking Alpha 12.26.10 | 01:12 am
